Tardive Dyskinesia Therapeutics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Tardive Dyskinesia Therapeutics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Growth Factors Of Tardive Dyskinesia Therapeutics Market

The tardive dyskinesia therapeutics market size was valued at USD 2.33 billion in 2022, and the market is now projected to grow from USD 2.77 billion in 2023 to USD 5.09 billion by 2030, exhibiting a CAGR of 9.1% during the forecast period of 2024-2032.

During COVID-19, non-COVID healthcare offerings, inclusive of those for uncommon situations such as tardive dyskinesia, confronted declines because of safety restrictions. Diagnoses and treatments have been hindered, with restrained get right of entry to diagnostics and drug healing procedures. Pharmaceutical organizations saw decreased prescription numbers as non-emergency corporations closed, slowing down treatment approvals.

One crucial driver undoubtedly impacting the worldwide market is the growing global incidence of tardive dyskinesia. This motion ailment can arise as a aspect impact of lengthy-time period use of sure psychiatric medicines such as antipsychotics. As antipsychotic tablets are increasingly used in the treatment of conditions including schizophrenia, schizoaffective ailment, and bipolar disease, the prevalence of tardive dyskinesia is rising as a consequence.

A triumphing trend within the global market is the upward push in projects by way of market players to boom consciousness approximately the treatment of tardive dyskinesia via diverse campaigns. Currently, the only accepted tablets for this condition are deutetrabenazine (AUSTEDO) by means of Teva Pharmaceutical Industries Ltd. And valbenazine (INGREZZA) with the aid of Neurocrine Biosciences, Inc. These groups are expanding their purchaser base via launching revolutionary campaigns to educate about the signs and engage sufferers in their treatment manner.

Comprehensive Analysis Of Tardive Dyskinesia Therapeutics Market

The tardive dyskinesia therapeutics market growth is rising at an exponential rate due to its market segmentation. This marketplace enlargement successfully affords an in-depth local exam thinking about the dominant deliver and demand forces that effect the enterprise. These segmentations are methodically segregated by drug analysis and by distribution channel analysis. By drug analysis include, deutetrabenazine, valbenazine, and others. By distribution channel analysis include, drug stores, online pharmacies, hospital pharmacies, and drug stores & retail pharmacies.

The North America region lead the tardive dyskinesia therapeutics market share by benefitting a market size of USD 2.24 billion in 2022 due to full-size recognition inside the populace regarding the disorder and growing help from many public and private institutions the use of studies endowments to fasten the look at for this disease.

The pinnacle players inside the market play a critical function in the enterprise assuring market growth and placing marketplace requirements. These players include, SOM Biotech (Spain), Luye Pharma Group (China), Mitsubishi Tanabe Pharma Corporation (Japan), Teva Pharmaceutical Industries Ltd. (Israel), Neurocrine Biosciences, Inc. (U.S.). These market players provide a level-playing competitive landscape.

In March 2022, The Ministry of Health, Labor and Welfare has granted regulatory approval to Mitsubishi Tanabe Pharma Corporation for the use of DYSVAL tablets 40mg, a vesicular monoamine transporter kind 2 (VMAT2) inhibitor, as tardive dyskinesia therapeutics.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2019-2030

Base Year 2022

Estimated Year 2023

Forecast Period 2023-2030

Historical Period 2019-2021

Growth Rate CAGR of 9.1% from 2023 to 2030

Unit Value (USD billion)

Segmentation By Drug, Distribution Channel, and Region

By Drug Deutetrabenazine

Valbenazine

Others

By Distribution Channel Hospital Pharmacies

Drug Stores & Retail Pharmacies

Online Pharmacies

By Region U.S. (By Drug, By Distribution Channel)

Europe (By Drug, By Distribution Channel, By Country/Sub-Region)

- Germany

- U.K.

- France

- Italy

- Spain

- Rest of Europe

Asia Pacific (By Drug, By Distribution Channel, By Country/Sub-Region)

- China

- Japan

- India

- Australia

- Rest of Asia Pacific

Rest of the World (By Drug, By Distribution Channel)


Please Note: It will take 5-6 business days to complete the report upon order confirmation.